Composite pH predicts esomeprazole response in laryngopharyngeal reflux without typical reflux syndrome
- 3 April 2013
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 123 (6) , 1483-1489
Abstract
Objectives/Hypothesis Factors predicting the efficacy of proton pump inhibitors (PPIs) in patients with suspected laryngopharyngeal reflux (LPR) are unclear. PPI treatment in patients without concomitant esophageal syndrome remains controversial. We investigated whether composite pH can predict PPI treatment response for LPR with or without concomitant typical reflux syndrome (CTRS). Study Design Prospective, open‐label therapeutic cohort study. Methods Patients with LPR in a tertiary center divided by presence (n = 65) and absence (n = 42) of CTRS underwent 24‐hour esophagopharyngeal pH test and took esomeprazole (40 mg, twice daily) for 12 weeks. Positive composite pH was defined as the presence of 1) excessive pharyngeal acid reflux, and/or 2) excessive distal esophageal acid reflux. A responder was defined as a patient with ≥50% reduction in primary laryngeal symptoms. The change in reflux symptoms was determined using the reflux symptom index (RSI) questionnaire. Logistic regression and mixed model were used to evaluate the predictability of the composite pH parameter. Results After 8 and 12 weeks of treatment, participants with positive composite pH were 10.3‐fold (95% confidence interval [CI], 1.7–61.5; P = .01) and 7.9‐fold (95% CI, 1.4–44.8; P = .02) more likely to respond, respectively, than participants with negative composite pH among patients without CTRS. However, no difference was found in those with CTRS. Weekly repeated measures of RSI yielded similar findings. Conclusions In patients with suspected LPR without CTRS, a composite pH parameter, which incorporates pharyngeal and distal esophageal acid reflux, may predict response to esomeprazole therapy. Level of Evidence 2bKeywords
This publication has 30 references indexed in Scilit:
- Predictors of acid suppression success in patients with chronic laryngitisNeurogastroenterology & Motility, 2012
- Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled studyAlimentary Pharmacology & Therapeutics, 2010
- Classical reflux symptoms, hiatus hernia and overweight independently predict pharyngeal acid exposure in patients with suspected reflux laryngitisAlimentary Pharmacology & Therapeutics, 2010
- Efficacy of Esomeprazole for Treatment of Poorly Controlled AsthmaNew England Journal of Medicine, 2009
- Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patientsThe Journal of Laryngology & Otology, 2008
- Treatment of Chronic Posterior Laryngitis With EsomeprazoleThe Laryngoscope, 2006
- Ear, nose, and throat manifestations of gastroesophageal reflux diseasePostgraduate Medicine, 2005
- Laryngopharyngeal Reflux Identified Using a New Catheter Design: Defining Normal Values and Excluding ArtifactsThe Laryngoscope, 2003
- Laryngopharyngeal Reflux Symptoms Improve Before Changes in Physical FindingsThe Laryngoscope, 2001
- A New Questionnaire for Gastroesophageal Reflux DiseaseMayo Clinic Proceedings, 1994